Skip to content

GLOBAL WHOLEHEALTH PARTNERS CORPORATION: 10-Q filed 2020-02-20

What GLOBAL WHOLEHEALTH PARTNERS CORPORATION reported in its quarterly report filed 2020-02-20 (fiscal Q2 2020): 18 published measures, 45 facts as tagged in accession 0001262463-20-000066.

This filing

Form
10-Q (quarterly report)
Filed
2020-02-20
Fiscal period
fiscal Q2 2020
Accession
0001262463-20-000066 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All GLOBAL WHOLEHEALTH PARTNERS CORPORATION filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2019-12-3123,469USD
At 2019-06-3019,918USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2019-12-3153,547USD
At 2019-06-30100USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2019-12-31-30,078USD
At 2019-09-301,020USD
At 2019-06-3019,818USD
At 2018-12-31-2,015USD
At 2018-09-30-1,715USD
At 2018-06-30-1,415USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2019-12-3197USD
At 2019-06-3019,918USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2019-10-01 to 2019-12-31-51,098USD92
2019-07-01 to 2019-12-31-69,896USD184
2019-07-01 to 2019-09-30-18,798USD92
2018-10-01 to 2018-12-31-300USD92
2018-07-01 to 2018-12-31-600USD184
2018-07-01 to 2018-09-30-300USD92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2019-07-01 to 2019-12-31-39,821USD184

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2019-07-01 to 2019-12-3120,000USD184

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2019-12-31-532,978USD
At 2019-06-30-463,082USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2019-10-01 to 2019-12-31-51,098USD92
2019-07-01 to 2019-12-31-69,896USD184
2018-10-01 to 2018-12-31-300USD92
2018-07-01 to 2018-12-31-600USD184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2019-12-3123,469USD
At 2019-06-3019,918USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2019-12-3153,547USD
At 2019-06-30100USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2019-10-01 to 2019-12-3151,098USD92
2019-07-01 to 2019-12-3169,896USD184
2018-10-01 to 2018-12-31300USD92
2018-07-01 to 2018-12-31600USD184

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2019-12-3123,372USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2019-10-01 to 2019-12-3129,698USD92
2019-07-01 to 2019-12-3133,996USD184
2018-10-01 to 2018-12-31300USD92
2018-07-01 to 2018-12-31600USD184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2019-12-3158,116,358shares
At 2019-06-3056,116,358shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2019-12-31444,784USD
At 2019-06-30426,784USD

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2019-07-01 to 2019-12-3120,000USD184

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2019-07-01 to 2019-12-3123,372USD184

Inspect the source

Entity
GLOBAL WHOLEHEALTH PARTNERS CORPORATION / CIK 0001598308
Captured
SEC response SHA-256
4f9d99cd872dc9722c93779ebb6b6945e30317a1ec9af0b414aed5d85fd78acc

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001598308.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))